191 related articles for article (PubMed ID: 22982637)
1. Debilitating progressive encephalitis in a patient with BTK deficiency.
Mohammadzadeh I; Yeganeh M; Khaledi M; Salehiomran MR; Aghamohammadi A; Rezaei N
Acta Microbiol Immunol Hung; 2012 Sep; 59(3):335-42. PubMed ID: 22982637
[TBL] [Abstract][Full Text] [Related]
2. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase--an integral protein of B cell development that also has an essential role in the innate immune system.
López-Herrera G; Vargas-Hernández A; González-Serrano ME; Berrón-Ruiz L; Rodríguez-Alba JC; Espinosa-Rosales F; Santos-Argumedo L
J Leukoc Biol; 2014 Feb; 95(2):243-50. PubMed ID: 24249742
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
[TBL] [Abstract][Full Text] [Related]
5. Mutations of Bruton's tyrosine kinase gene in Brazilian patients with X-linked agammaglobulinemia.
Ramalho VD; Oliveira Júnior EB; Tani SM; Roxo Júnior P; Vilela MM
Braz J Med Biol Res; 2010 Sep; 43(9):910-3. PubMed ID: 20721470
[TBL] [Abstract][Full Text] [Related]
6. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
7. A new mutation that predicted a drastic alteration of the BTK protein function.
Debost-Legrand A; Legrand G; Moulillot G; Francannet C; Bocly B; Theodoroub I; Paillard C
Gene; 2013 Sep; 527(1):426-8. PubMed ID: 23774691
[TBL] [Abstract][Full Text] [Related]
8. [Detection of Bruton's tyrosine kinase gene mutations and clinical analysis of 6 patients with X-linked agammaglobulinemia].
Zhang X; Li H; Li Q; Gao J; Shi X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):29-33. PubMed ID: 24510558
[TBL] [Abstract][Full Text] [Related]
9. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.
Gao S; Hu S; Duan H; Wang L; Kong X
BMC Med Genet; 2020 Jun; 21(1):131. PubMed ID: 32552675
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel non-pathogenic mutation in SH3 domain of Btk in an XLA patient.
Pérez de Diego R; Bravo J; Allende LM; López-Granados E; Rivera J; Ferreira A; Fontán G; García Rodríguez MC
Mol Immunol; 2008 Jan; 45(1):301-3. PubMed ID: 17707910
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia.
Boushaki S; Tahiat A; Meddour Y; Chan KW; Chaib S; Benhalla N; Smati L; Bensenouci A; Lau YL; Magdinier F; Djidjik R
Clin Immunol; 2015 Dec; 161(2):286-90. PubMed ID: 26387629
[TBL] [Abstract][Full Text] [Related]
13. A novel BTK gene mutation creates a de-novo splice site in an X-linked agammaglobulinemia patient.
Chear CT; Ripen AM; Mohamed SA; Dhaliwal JS
Gene; 2015 Apr; 560(2):245-8. PubMed ID: 25680287
[TBL] [Abstract][Full Text] [Related]
14. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
[TBL] [Abstract][Full Text] [Related]
15. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
Fiorini M; Franceschini R; Soresina A; Schumacher RF; Ugazio AG; Rossi P; Plebani A; Notarangelo LD
Hum Mutat; 2004 Mar; 23(3):286. PubMed ID: 14974089
[TBL] [Abstract][Full Text] [Related]
16. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
17. Familial hemophagocytic lymphohistiocytosis in two brothers with X-linked agammaglobulinemia.
Schultz KA; Neglia JP; Smith AR; Ochs HD; Torgerson TR; Kumar A
Pediatr Blood Cancer; 2008 Aug; 51(2):293-5. PubMed ID: 18421721
[TBL] [Abstract][Full Text] [Related]
18. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic analysis of X-linked hypogammaglobulinemia and isolated growth hormone deficiency.
Stewart DM; Notarangelo LD; Kurman CC; Staudt LM; Nelson DL
J Immunol; 1995 Sep; 155(5):2770-4. PubMed ID: 7650402
[TBL] [Abstract][Full Text] [Related]
20. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
Schuster V; Seidenspinner S; Kreth HW
Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
